Market revenue in 2023 | USD 1,991.1 million |
Market revenue in 2030 | USD 3,424.7 million |
Growth rate | 8.1% (CAGR from 2023 to 2030) |
Largest segment | Polyphenylsulfone (ppsu) |
Fastest growing segment | Polypropylene (PP) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene (PE), Polypropylene (PP), Polycarbonate (PC), Liquid Crystal Polymer (LCP), Polyphenylsulfone (PPSU), Polyethersulfone (PES), Polyethylenimine (PEI), Polymethyl Methacrylate (PMMA) |
Key market players worldwide | Röchling Group, Nolato AB Class B, Compagnie de Saint-Gobain SA, SABIC, Orthoplastics, Eastman Chemical Co, Celanese Corp Class A, Dow Inc, Tekni-Plex, Solvay SA, Hmc Polymers Company, Integer Holdings Corp, Trelleborg AB ADR, Avantor Inc, Trinseo PLC, Evonik Industries AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical plastic market will help companies and investors design strategic landscapes.
Polyphenylsulfone (ppsu) was the largest segment with a revenue share of 41.75% in 2023. Horizon Databook has segmented the Japan medical plastic market based on polyethylene (pe), polypropylene (pp), polycarbonate (pc), liquid crystal polymer (lcp), polyphenylsulfone (ppsu), polyethersulfone (pes), polyethylenimine (pei), polymethyl methacrylate (pmma) covering the revenue growth of each sub-segment from 2018 to 2030.
Medical plastics market in Japan is expected to witness high growth over the forecast period on account of increasing demand in end-use applications. Moreover, increasing healthcare costs in the country, on account of the prevalence of expensive and innovative treatments, are expected to drive the demand for medical plastics over the forecast period.
The rising prevalence of diseases among the aging population has increased the demand for medical plastics coupled with the highly reformed healthcare sector in the country, which is expected to increase healthcare spending in Japan. This is expected to drive the demand for medical plastics in Japan over the forecast period.
According to the World Economic Forum (WEF), Japan has the highest percentage of 29.8% of the total population of people aged 65 years or above. Additionally, by the end of the third quarter of 2023, the proportion of individuals aged 80 or older in Japan surpassed the 10% level, indicating a significant demographic shift in the country with continuously increasing aging population.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan medical plastic market , including forecasts for subscribers. This country databook contains high-level insights into Japan medical plastic market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account